This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Glaucoma  • Prostheses/ Implants  • Alert me on articles by topic  Social Bookmarking   What's this?

A Pilot Study

Shlomo Melamed, MD; Guy J. Ben Simon, MD; Modi Goldenfeld, MD; Gabriel Simon, MD

Arch Ophthalmol. 2009;127(3):264-269.

Purpose  To evaluate the safety and efficacy of Gold Micro Shunt (GMS) implantation to the supraciliary space in patients with glaucoma.

Methods  A total of 38 patients with glaucoma with uncontrolled intraocular pressure (IOP) underwent implantation of the GMS in this prospective 2-center study.

Main Outcome Measures  Intraocular pressure and surgical complications.

Results  A total of 38 patients with glaucoma participated. The mean follow-up time was 11.7 months. The IOP decreased a mean (SD) of 9 mm Hg from 27.6 (4.7) to 18.2 (4.6) mm Hg (P < .001). Surgical success was achieved in 30 patients (79%) (IOP >5 and <22 mm Hg, with or without antiglaucoma medication). Eight patients had mild to moderate transient hyphema.

Conclusions  Implantation of GMS to the supraciliary space is a safe and effective method of controlling IOP in patients with glaucoma. Use of the GMS resulted in a significant decrease in IOP.

Application to Clinical Practice  The GMS could be an alternative surgical device to standard trabeculectomy.

Author Affiliations: The Sam Rothberg Glaucoma Center, Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, and Tel Aviv University, Sackler School of Medicine, Tel Aviv, Israel (Drs Melamed and Goldenfeld); and the Simon Ophthalmology Institute, Barcelona, Spain (Dr Simon).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?